Literature DB >> 1706316

Protection of immunosuppressed mice against infection with Pseudomonas aeruginosa by recombinant P. aeruginosa lipoprotein I and lipoprotein I-specific monoclonal antibodies.

M Finke1, G Muth, T Reichhelm, M Thoma, M Duchêne, K D Hungerer, H Domdey, B U von Specht.   

Abstract

Outer membrane protein I (OprI) is one of the major proteins of the outer membrane of Pseudomonas aeruginosa. The protective effect of OprI vaccination and that of three OprI-specific monoclonal antibodies (MAbs) against infection with P. aeruginosa were tested in immunosuppressed mice. The combination of Oprl and MAb 2A1 protected the mice against a challenge with a 96-fold 50% lethal dose. The binding site of MAb 2A1 was mapped, resulting in the identification of a protective epitope (amino acids 7 to 20).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1706316      PMCID: PMC257835          DOI: 10.1128/iai.59.4.1251-1254.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.

Authors:  M Finke; M Duchêne; A Eckhardt; H Domdey; B U von Specht
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Characterization of two surface-localized antigenic sites on porin protein F of Pseudomonas aeruginosa.

Authors:  L M Mutharia; R E Hancock
Journal:  Can J Microbiol       Date:  1985-04       Impact factor: 2.419

5.  Mechanism of action of the lexA gene product.

Authors:  R Brent; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

6.  Pseudomonas aeruginosa outer membrane lipoprotein I gene: molecular cloning, sequence, and expression in Escherichia coli.

Authors:  M Duchêne; C Barron; A Schweizer; B U von Specht; H Domdey
Journal:  J Bacteriol       Date:  1989-08       Impact factor: 3.490

7.  Outer membrane of Pseudomonas aeruginosa: heat- 2-mercaptoethanol-modifiable proteins.

Authors:  R E Hancock; A M Carey
Journal:  J Bacteriol       Date:  1979-12       Impact factor: 3.490

8.  Lipoprotein from the outer membrane of Escherichia coli: purification, paracrystallization, and some properties of its free form.

Authors:  S Inoyye; K Takeishi; N Lee; M DeMartini; A Hirashima; M Inouye
Journal:  J Bacteriol       Date:  1976-07       Impact factor: 3.490

9.  Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Outer membrane proteins of Pseudomonas aeruginosa serotype strains.

Authors:  L M Mutharia; T I Nicas; R E Hancock
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

View more
  9 in total

Review 1.  Recent developments for Pseudomonas vaccines.

Authors:  Anurag Sharma; Anja Krause; Stefan Worgall
Journal:  Hum Vaccin       Date:  2011-10-01

2.  Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.

Authors:  E Mansouri; J Gabelsberger; B Knapp; E Hundt; U Lenz; K D Hungerer; H E Gilleland; J Staczek; H Domdey; B U von Specht
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

3.  Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice.

Authors:  Jennifer M Scarff; Joanna B Goldberg
Journal:  Clin Vaccine Immunol       Date:  2007-12-19

4.  Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.

Authors:  B U von Specht; B Knapp; G Muth; M Bröker; K D Hungerer; K D Diehl; K Massarrat; A Seemann; H Domdey
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

5.  A role for CD4+ T cells from orally immunized rats in enhanced clearance of Pseudomonas aeruginosa from the lung.

Authors:  M L Dunkley; R L Clancy; A W Cripps
Journal:  Immunology       Date:  1994-11       Impact factor: 7.397

6.  Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.

Authors:  A W Cripps; M L Dunkley; R L Clancy
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

7.  Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).

Authors:  K Hatano; J B Goldberg; G B Pier
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.

Authors:  Bhavani V Peddayelachagiri; Soumya Paul; Shivakiran S Makam; Radhika M Urs; Joseph J Kingston; Urmil Tuteja; Murali H Sripathy; Harsh V Batra
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

Review 9.  Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.

Authors:  Maite Sainz-Mejías; Irene Jurado-Martín; Siobhán McClean
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.